Kala Pharmaceuticals, Inc.
Kala Pharmaceuticals, Inc. (KALA) is a publicly traded company in the Unknown sector. Across all available filings, 29 corporate insiders have executed 221 transactions totaling $220.3M, demonstrating a bullish sentiment with $212.6M in net insider flow. The most recent transaction on Oct 23, 2025 involved a sale of 967 shares valued at $793.
KALA Insider Activity Summary
Who Is Buying KALA Stock?
No significant insider buying has been recorded for KALA in the recent period.
Who Is Selling KALA Stock?
No significant insider selling has been recorded for KALA in the recent period.
Is Kala Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KALA is bullish with an Insider Alignment Score of 98/100 and a net flow of $212.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
KALA Frequently Asked Questions
Understanding KALA Insider Activity
Insider trading at Kala Pharmaceuticals, Inc. (KALA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 29 insiders are actively trading KALA stock, having executed 221 transactions in the past 90 days. The most active insider is Rajeev M. Shah (Executive), who has made 9 transactions totaling $79.5M.
Related Tools
Track Kala Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at KALA file new Form 4 transactions